Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.447
-0.003 (-0.23%)
Nov 4, 2024, 4:00 PM EST - Market closed

Barinthus Biotherapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for BRNS stock have an average target of 4.00, with a low estimate of 3.00 and a high estimate of 5.00. The average target predicts an increase of 176.51% from the current stock price of 1.45.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $3.00 $4.00 $5.00 $5.00
Change +107.38% +176.51% +245.64% +245.64%
* Price targets were last updated on Oct 1, 2024.

Analyst Ratings

The average analyst rating for BRNS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 111111
Buy 011111
Hold 000000
Sell 000000
Strong Sell 000000
Total 122222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +245.64% Oct 1, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +245.64% Sep 26, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +245.64% Aug 12, 2024
Barclays
Barclays
Buy
Maintains
$7$3
Buy Maintains $7$3 +107.38% Jun 13, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +453.02% Jun 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 802.00K
Revenue Next Year
n/a
EPS This Year
-1.74
from -1.91
EPS Next Year
-1.65
from -1.74
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
6.85M4.82M268.00K44.70M802.00K---
Revenue Growth
--29.57%-94.44%16,580.22%-98.21%---
EPS
-883.28-2.24-1.960.14-1.91-1.74-1.65-1.66
EPS Growth
--------
Forward PE
--------
No. Analysts -----665
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -1.67 -1.33 -1.48
Avg -1.74 -1.65 -1.66
Low -1.78 -1.85 -1.81

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.